论文部分内容阅读
1967年Norplant皮下埋植避孕剂开始在临床试用,已经证明该法是一种安全、高效、可逆、一次埋植避孕效果可超过5年的避孕方法。大量临床资料,涉及育龄妇女对该法的可接受性。影响可接受性的因素包括宗教、对待避孕的文化差异,副作用以及提供服务者的态度。在美国Colorado综合大学健康科学中心(UCHSC)妇产科,对4组不同Norplant受术者,即青春期少女,居民,护士、助产士和医生进行研究,比较其人口统计学特征,主要副作用,分析取出原因以判断其可接受性。
1967 Norplant subcutaneously contraceptive contraceptive began clinical trials, the law has proved to be a safe, efficient, reversible, a contraceptive effect implanted in more than 5 years can be contrasted. Numerous clinical data on the acceptability of women of childbearing age to this law. Factors that affect acceptability include religion, cultural differences in contraception, side effects and attitude toward service delivery. At the Department of Obstetrics and Gynecology, University of Colorado Health Sciences Center (UCHSC), four groups of Norplant patients, adolescent girls, residents, nurses, midwives and physicians were studied, their demographic characteristics and major side effects were compared and analyzed Reason to judge its acceptability.